Physiologically Based Precision Dosing Approach for Drug‐Drug‐Gene Interactions: A Simvastatin Network Analysis-Reference-Cited by-同舟云学术

Physiologically Based Precision Dosing Approach for Drug‐Drug‐Gene Interactions: A Simvastatin Network Analysis

Published:2020-12-06 Issue:1 Volume:109 Page:201-211
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Wojtyniak Jan‐Georg¹²^ORCID,Selzer Dominik¹,Schwab Matthias²³⁴,Lehr Thorsten¹^ORCID

Affiliation:

1. Clinical Pharmacy Saarland University Saarbrücken Germany

2. Dr. Margarete Fischer‐Bosch‐Institute of Clinical Pharmacology Stuttgart Germany

3. Departments of Clinical Pharmacology and Pharmacy and Biochemistry University of Tübingen Tübingen Germany

4. Cluster of Excellence iFIT (EXC2180) "Image‐guided and Functionally Instructed Tumor Therapies" University of Tübingen Tübingen Germany

Funder

Robert Bosch

European Commission

Horizon 2020 Framework Programme

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2111

Reference56 articles.

1. Elsevier.Elsevier joins forces with pharmaceutical industry leaders to build new drug‐drug interaction risk calculator (2019). Accessed July 12 2020.

2. US Food and Drug Administration.Preventable adverse drug reactions: a focus on drug interactions (2018). Accessed July 12 2020.

3. Carr T.Too many meds? America’s love affair with prescription medication (2017). Accessed July 12 2020.

4. Drug–drug–gene interactions and adverse drug reactions

5. How common are drug and gene interactions? Prevalence in a sample of 1143 patients with CYP2C9, CYP2C19 and CYP2D6 genotyping

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into pharmacogenetics, drug-gene interactions, and drug-drug-gene interactions;Drug Metabolism Reviews;2024-08-18

2. A physiologically‐based pharmacokinetic precision dosing approach to manage dasatinib drug–drug interactions;CPT: Pharmacometrics & Systems Pharmacology;2024-05

3. Physiologically based pharmacokinetic modeling of imatinib and N‐desmethyl imatinib for drug–drug interaction predictions;CPT: Pharmacometrics & Systems Pharmacology;2024-03-14

4. Circulating Biomarkers Instead of Genotyping to Establish Metabolizer Phenotypes;Annual Review of Pharmacology and Toxicology;2024-01-23

5. Implementation of pre‐emptive testing of a pharmacogenomic panel in clinical practice: Where do we stand?;British Journal of Clinical Pharmacology;2023-12-21